7467-13-2 Usage
Uses
Used in Organic Synthesis:
(1Z)-3-ethoxycyclohex-2-en-1-one oxime is utilized as a key intermediate in organic synthesis for the production of various organic compounds. Its reactivity and the ability to participate in multiple types of chemical reactions make it a versatile building block in the synthesis of complex organic molecules.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, (1Z)-3-ethoxycyclohex-2-en-1-one oxime is used as a reagent in the synthesis of pharmaceuticals. Its unique structure allows it to be a part of the development of new drugs, contributing to the creation of molecules with potential therapeutic applications.
Used in Agrochemical Production:
(1Z)-3-ethoxycyclohex-2-en-1-one oxime also finds application in the agrochemical sector, where it serves as an intermediate in the synthesis of agrochemicals. Its role in this industry is crucial for the development of new compounds that can be used in agriculture for pest control and crop protection.
Overall, (1Z)-3-ethoxycyclohex-2-en-1-one oxime is a valuable compound in the fields of organic synthesis, pharmaceuticals, and agrochemicals due to its unique properties and reactivity, making it an essential component in the development of new and innovative products.
Check Digit Verification of cas no
The CAS Registry Mumber 7467-13-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,4,6 and 7 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 7467-13:
(6*7)+(5*4)+(4*6)+(3*7)+(2*1)+(1*3)=112
112 % 10 = 2
So 7467-13-2 is a valid CAS Registry Number.
7467-13-2Relevant articles and documents
FUSED THIOPHENE AND THIAZOLE DERIVATIVES AS ROR GAMMA MODULATORS
-
Page/Page column 76; 77, (2015/07/16)
The present invention provides fused thiophene and thiazole derivatives of formula (I), which may be therapeutically useful, more particularly as RORγ modulators; in which R1, R2, R3, R4, R5, R6, R7, X1, X2, L, m, n and ring A have the meanings given in the specification, and pharmaceutically acceptable salts thereof that are useful in the treatment and prevention of diseases or disorders, in particular their use in disease(s) or disorder(s) where there is an advantage in modulating RORγ receptor. The present invention also provides preparation of the compounds and pharmaceutical formulations comprising at least one of the fused thiophene and thiazole derivatives of formula (I), together with a pharmaceutically acceptable carrier, diluent or excipient therefor.
